A new update (version 23/07) is now available. The update contains the following functional and technical and improvements: A history of stock movements is stored in the database and can be accessed via the menu Creation of templates for uniform naming of cases...
The data collected since the beginning of the year show a trend again. We looked at the following fours over time, based on age and positive rate: RSV, H1N1, influenza A combined, and influenza B. Thereby we can prove a significant increase of influenza B after the...
We have implemented a new helpful function in our software. This way, complex relationships between samples from a lineage are displayed in a graph in a very clear and descriptive way. In our video https://www.youtube.com/watch?v=Ts7TOd9-zhU we show how to create a...
Dear interested parties, in today's newsletter we would like to introduce our software for the management of your laboratory samples (biochemicals/GMO, diagnostics etc.). We offer the right product and the experience of many years to raise the management of your...
For more than ten years, MEDEORA has supported the Clinical Virology Net (CVN: https://public.clinical-virology.net/). There, data on respiratory viruses and bacteria are collected and presented in a way that is accessible to the public. Here one can read in detail...
The Clinical Virology Network (https://public.clinical-virology.net) aims to inform interested physicians and scientists across geographical and organizational boundaries about the current epidemic spread of infectious diseases and their pathogens. MEDEORA continues...
We are pleased to announce that the technical article on respiratory viruses, to which our managing director Dr. Norbert Schmeißer contributed significantly, has now been published. The article deals with a 10-year observation of seasonality, co-infection and...
We have used the year 2021 to reorganize our product range.So it seemed right and important to us to redesign the logo and the websites.These changes have been incorporated into our new website.The logo itself stands associatively for the topics of research and...
Dear customers, supporters and interested parties, Today we would like to inform you in advance about the upcoming innovations at MEDEORA. On 12 December 2012, Dr Norbert Schmeißer took over MEDEORA GmbH as sole managing director. So we find the timing very successful...
Date - Home BioRiver Events Dear people responsible for quality control, clinical research and IT, We would like to invite you to an exchange of experiences in the IT working group of BioRiver eV! The next appointment: 8. working group IT in BioRiver eV IT - supported...
NEWS
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
